Australia's most trusted
source of pharma news
Posted 10 December 2025 PM
The pharma industry packed into the main room at the NEXT Pharma Summit in a bid to understand the culture conundrum in pharma, and hung on the words of Pierre Fabre Medical Affairs Director APAC Oncology, Dr Sarah Tregenza, as she presented three steps to getting culture right.
For the executives in the audience she pulled out some studies on the business value of having a good culture, starting with a Harvard 11-year study of more than 200 companies which found that organisations that focused on shaping their culture outperformed their competitors with 4.1 times revenues, 12.2 times stock price, 756 per cent higher net income, and 15 times return on investment.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.